查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1858714

纖維蛋白原濃縮物－全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Fibrinogen Concentrate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 96 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球纖維蛋白原濃縮物市場規模預計為 12.6 億美元，預計到 2031 年將達到 25.62 億美元，在預測期（2025-2031 年）內複合年成長率為 10.5%。

本報告對近期關稅調整和國際戰略反制措施對纖維蛋白原濃縮物跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響進行了全面評估。

纖維蛋白原濃縮物是由人類血漿或重組蛋白高度純化的血漿蛋白，其主要成分為纖維蛋白原。纖維蛋白原在血液凝固過程中發揮至關重要的作用，它可被凝血酶轉化為纖維蛋白，促進血液凝固並幫助止血。纖維蛋白原濃縮物主要用於治療先天性或後天性纖維蛋白原缺乏症，控制手術或創傷期間的出血，以及其他需要快速補充纖維蛋白原的情況。

纖維蛋白原濃縮物市場的主要促進因素包括出血性疾病盛行率的上升、需要快速止血的外科手術數量的增加，以及人們對標靶血液管理療法的認知和應用日益提高。血漿分餾和重組技術的進步，以及對更安全、病原體減少和高純度血液製品的需求不斷成長，也是推動市場成長的因素。此外，人口老化、創傷和心血管手術發生率的上升，以及新興地區醫療基礎設施的持續改善，也促進了對纖維蛋白原濃縮物需求的成長。

該行業的主要生產商是 CSL Behring、LFB 集團和上海瑞斯血液製品有限公司，到 2024 年，它們的市佔率分別為 52%、20% 和 10%。

本報告旨在按地區/國家、類型和應用對全球纖維蛋白原濃縮物市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以2024年為基準年，透過銷售量（公斤）和收入（百萬美元）對纖維蛋白原濃縮物市場規模、估算和預測進行呈現，並涵蓋2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定纖維蛋白原濃縮物業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • CSL Behring
  • LFB Group
  • Shanghai RAAS
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Octapharma

按類型分類的細分市場

  • 人類纖維蛋白原濃縮物
  • 其他

應用領域

  • 外科手術
  • 先天性纖維蛋白原缺乏症
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Fibrinogen Concentrate was estimated to be worth US$ 1260 million in 2024 and is forecast to a readjusted size of US$ 2562 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fibrinogen Concentrate cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Fibrinogen concentrate is a high-purity plasma protein preparation derived from human plasma or produced through recombinant technology, with fibrinogen as its main component. It plays a crucial role in blood clotting, as fibrinogen is converted into fibrin by thrombin to form a blood clot and stop bleeding. Fibrinogen concentrate is primarily used to treat congenital or acquired fibrinogen deficiencies, manage bleeding during surgery or trauma, and address other conditions requiring rapid fibrinogen supplementation.

The market for fibrinogen concentrate is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.

The major producers in the industry are CSL Behring, LFB Group and Shanghai RAAS Blood Products, whose revenue ratios in 2024 are 52%, 20% and 10% respectively.

This report aims to provide a comprehensive presentation of the global market for Fibrinogen Concentrate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fibrinogen Concentrate by region & country, by Type, and by Application.

The Fibrinogen Concentrate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibrinogen Concentrate.

Market Segmentation

By Company

  • CSL Behring
  • LFB Group
  • Shanghai RAAS
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Octapharma

Segment by Type

  • Human Fibrinogen Concentrate
  • Others

Segment by Application

  • Surgical Procedures
  • Congenital Fibrinogen Deficiency
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fibrinogen Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Fibrinogen Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Fibrinogen Concentrate in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Fibrinogen Concentrate Product Introduction
  • 1.2 Global Fibrinogen Concentrate Market Size Forecast
    • 1.2.1 Global Fibrinogen Concentrate Sales Value (2020-2031)
    • 1.2.2 Global Fibrinogen Concentrate Sales Volume (2020-2031)
    • 1.2.3 Global Fibrinogen Concentrate Sales Price (2020-2031)
  • 1.3 Fibrinogen Concentrate Market Trends & Drivers
    • 1.3.1 Fibrinogen Concentrate Industry Trends
    • 1.3.2 Fibrinogen Concentrate Market Drivers & Opportunity
    • 1.3.3 Fibrinogen Concentrate Market Challenges
    • 1.3.4 Fibrinogen Concentrate Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Fibrinogen Concentrate Players Revenue Ranking (2024)
  • 2.2 Global Fibrinogen Concentrate Revenue by Company (2020-2025)
  • 2.3 Global Fibrinogen Concentrate Players Sales Volume Ranking (2024)
  • 2.4 Global Fibrinogen Concentrate Sales Volume by Company Players (2020-2025)
  • 2.5 Global Fibrinogen Concentrate Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Fibrinogen Concentrate Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Fibrinogen Concentrate Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Fibrinogen Concentrate
  • 2.9 Fibrinogen Concentrate Market Competitive Analysis
    • 2.9.1 Fibrinogen Concentrate Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Fibrinogen Concentrate Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen Concentrate as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Human Fibrinogen Concentrate
    • 3.1.2 Others
  • 3.2 Global Fibrinogen Concentrate Sales Value by Type
    • 3.2.1 Global Fibrinogen Concentrate Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Fibrinogen Concentrate Sales Value, by Type (2020-2031)
    • 3.2.3 Global Fibrinogen Concentrate Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Fibrinogen Concentrate Sales Volume by Type
    • 3.3.1 Global Fibrinogen Concentrate Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Fibrinogen Concentrate Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Fibrinogen Concentrate Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Fibrinogen Concentrate Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Surgical Procedures
    • 4.1.2 Congenital Fibrinogen Deficiency
    • 4.1.3 Others
  • 4.2 Global Fibrinogen Concentrate Sales Value by Application
    • 4.2.1 Global Fibrinogen Concentrate Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Fibrinogen Concentrate Sales Value, by Application (2020-2031)
    • 4.2.3 Global Fibrinogen Concentrate Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Fibrinogen Concentrate Sales Volume by Application
    • 4.3.1 Global Fibrinogen Concentrate Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Fibrinogen Concentrate Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Fibrinogen Concentrate Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Fibrinogen Concentrate Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Fibrinogen Concentrate Sales Value by Region
    • 5.1.1 Global Fibrinogen Concentrate Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Fibrinogen Concentrate Sales Value by Region (2020-2025)
    • 5.1.3 Global Fibrinogen Concentrate Sales Value by Region (2026-2031)
    • 5.1.4 Global Fibrinogen Concentrate Sales Value by Region (%), (2020-2031)
  • 5.2 Global Fibrinogen Concentrate Sales Volume by Region
    • 5.2.1 Global Fibrinogen Concentrate Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Fibrinogen Concentrate Sales Volume by Region (2020-2025)
    • 5.2.3 Global Fibrinogen Concentrate Sales Volume by Region (2026-2031)
    • 5.2.4 Global Fibrinogen Concentrate Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Fibrinogen Concentrate Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Fibrinogen Concentrate Sales Value, 2020-2031
    • 5.4.2 North America Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Fibrinogen Concentrate Sales Value, 2020-2031
    • 5.5.2 Europe Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Fibrinogen Concentrate Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Fibrinogen Concentrate Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Fibrinogen Concentrate Sales Value, 2020-2031
    • 5.7.2 South America Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Fibrinogen Concentrate Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Fibrinogen Concentrate Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Fibrinogen Concentrate Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Fibrinogen Concentrate Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Fibrinogen Concentrate Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Fibrinogen Concentrate Sales Value, 2020-2031
    • 6.3.2 United States Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Fibrinogen Concentrate Sales Value, 2020-2031
    • 6.4.2 Europe Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Fibrinogen Concentrate Sales Value, 2020-2031
    • 6.5.2 China Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Fibrinogen Concentrate Sales Value, 2020-2031
    • 6.6.2 Japan Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Fibrinogen Concentrate Sales Value, 2020-2031
    • 6.7.2 South Korea Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Fibrinogen Concentrate Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Fibrinogen Concentrate Sales Value, 2020-2031
    • 6.9.2 India Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 CSL Behring
    • 7.1.1 CSL Behring Company Information
    • 7.1.2 CSL Behring Introduction and Business Overview
    • 7.1.3 CSL Behring Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 CSL Behring Fibrinogen Concentrate Product Offerings
    • 7.1.5 CSL Behring Recent Development
  • 7.2 LFB Group
    • 7.2.1 LFB Group Company Information
    • 7.2.2 LFB Group Introduction and Business Overview
    • 7.2.3 LFB Group Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 LFB Group Fibrinogen Concentrate Product Offerings
    • 7.2.5 LFB Group Recent Development
  • 7.3 Shanghai RAAS
    • 7.3.1 Shanghai RAAS Company Information
    • 7.3.2 Shanghai RAAS Introduction and Business Overview
    • 7.3.3 Shanghai RAAS Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shanghai RAAS Fibrinogen Concentrate Product Offerings
    • 7.3.5 Shanghai RAAS Recent Development
  • 7.4 China Resources Boya Bio-pharmaceutical
    • 7.4.1 China Resources Boya Bio-pharmaceutical Company Information
    • 7.4.2 China Resources Boya Bio-pharmaceutical Introduction and Business Overview
    • 7.4.3 China Resources Boya Bio-pharmaceutical Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 China Resources Boya Bio-pharmaceutical Fibrinogen Concentrate Product Offerings
    • 7.4.5 China Resources Boya Bio-pharmaceutical Recent Development
  • 7.5 Hualan Biological Engineering
    • 7.5.1 Hualan Biological Engineering Company Information
    • 7.5.2 Hualan Biological Engineering Introduction and Business Overview
    • 7.5.3 Hualan Biological Engineering Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hualan Biological Engineering Fibrinogen Concentrate Product Offerings
    • 7.5.5 Hualan Biological Engineering Recent Development
  • 7.6 Harbin Pacific Biopharmaceutical
    • 7.6.1 Harbin Pacific Biopharmaceutical Company Information
    • 7.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview
    • 7.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Product Offerings
    • 7.6.5 Harbin Pacific Biopharmaceutical Recent Development
  • 7.7 China Meheco Group
    • 7.7.1 China Meheco Group Company Information
    • 7.7.2 China Meheco Group Introduction and Business Overview
    • 7.7.3 China Meheco Group Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 China Meheco Group Fibrinogen Concentrate Product Offerings
    • 7.7.5 China Meheco Group Recent Development
  • 7.8 Octapharma
    • 7.8.1 Octapharma Company Information
    • 7.8.2 Octapharma Introduction and Business Overview
    • 7.8.3 Octapharma Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Octapharma Fibrinogen Concentrate Product Offerings
    • 7.8.5 Octapharma Recent Development

8 Industry Chain Analysis

  • 8.1 Fibrinogen Concentrate Industrial Chain
  • 8.2 Fibrinogen Concentrate Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Fibrinogen Concentrate Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Fibrinogen Concentrate Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Fibrinogen Concentrate Market Trends
  • Table 2. Fibrinogen Concentrate Market Drivers & Opportunity
  • Table 3. Fibrinogen Concentrate Market Challenges
  • Table 4. Fibrinogen Concentrate Market Restraints
  • Table 5. Global Fibrinogen Concentrate Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Fibrinogen Concentrate Revenue Market Share by Company (2020-2025)
  • Table 7. Global Fibrinogen Concentrate Sales Volume by Company (2020-2025) & (Kg)
  • Table 8. Global Fibrinogen Concentrate Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Fibrinogen Concentrate Price by Company (2020-2025) & (US$/g)
  • Table 10. Key Manufacturers Fibrinogen Concentrate Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Fibrinogen Concentrate Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Fibrinogen Concentrate
  • Table 13. Global Fibrinogen Concentrate Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen Concentrate as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Fibrinogen Concentrate Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Fibrinogen Concentrate Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Fibrinogen Concentrate Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Fibrinogen Concentrate Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Fibrinogen Concentrate Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Fibrinogen Concentrate Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
  • Table 22. Global Fibrinogen Concentrate Sales Volume by Type (2020-2025) & (Kg)
  • Table 23. Global Fibrinogen Concentrate Sales Volume by Type (2026-2031) & (Kg)
  • Table 24. Global Fibrinogen Concentrate Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Fibrinogen Concentrate Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Fibrinogen Concentrate Price by Type (2020-2025) & (US$/g)
  • Table 27. Global Fibrinogen Concentrate Price by Type (2026-2031) & (US$/g)
  • Table 28. Global Fibrinogen Concentrate Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Fibrinogen Concentrate Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Fibrinogen Concentrate Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Fibrinogen Concentrate Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Fibrinogen Concentrate Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Fibrinogen Concentrate Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
  • Table 34. Global Fibrinogen Concentrate Sales Volume by Application (2020-2025) & (Kg)
  • Table 35. Global Fibrinogen Concentrate Sales Volume by Application (2026-2031) & (Kg)
  • Table 36. Global Fibrinogen Concentrate Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Fibrinogen Concentrate Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Fibrinogen Concentrate Price by Application (2020-2025) & (US$/g)
  • Table 39. Global Fibrinogen Concentrate Price by Application (2026-2031) & (US$/g)
  • Table 40. Global Fibrinogen Concentrate Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Fibrinogen Concentrate Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Fibrinogen Concentrate Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Fibrinogen Concentrate Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Fibrinogen Concentrate Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Fibrinogen Concentrate Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
  • Table 46. Global Fibrinogen Concentrate Sales Volume by Region (2020-2025) & (Kg)
  • Table 47. Global Fibrinogen Concentrate Sales Volume by Region (2026-2031) & (Kg)
  • Table 48. Global Fibrinogen Concentrate Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Fibrinogen Concentrate Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Fibrinogen Concentrate Average Price by Region (2020-2025) & (US$/g)
  • Table 51. Global Fibrinogen Concentrate Average Price by Region (2026-2031) & (US$/g)
  • Table 52. Key Countries/Regions Fibrinogen Concentrate Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Fibrinogen Concentrate Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Fibrinogen Concentrate Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Fibrinogen Concentrate Sales Volume, (2020-2025) & (Kg)
  • Table 56. Key Countries/Regions Fibrinogen Concentrate Sales Volume, (2026-2031) & (Kg)
  • Table 57. CSL Behring Company Information
  • Table 58. CSL Behring Introduction and Business Overview
  • Table 59. CSL Behring Fibrinogen Concentrate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 60. CSL Behring Fibrinogen Concentrate Product Offerings
  • Table 61. CSL Behring Recent Development
  • Table 62. LFB Group Company Information
  • Table 63. LFB Group Introduction and Business Overview
  • Table 64. LFB Group Fibrinogen Concentrate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 65. LFB Group Fibrinogen Concentrate Product Offerings
  • Table 66. LFB Group Recent Development
  • Table 67. Shanghai RAAS Company Information
  • Table 68. Shanghai RAAS Introduction and Business Overview
  • Table 69. Shanghai RAAS Fibrinogen Concentrate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 70. Shanghai RAAS Fibrinogen Concentrate Product Offerings
  • Table 71. Shanghai RAAS Recent Development
  • Table 72. China Resources Boya Bio-pharmaceutical Company Information
  • Table 73. China Resources Boya Bio-pharmaceutical Introduction and Business Overview
  • Table 74. China Resources Boya Bio-pharmaceutical Fibrinogen Concentrate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 75. China Resources Boya Bio-pharmaceutical Fibrinogen Concentrate Product Offerings
  • Table 76. China Resources Boya Bio-pharmaceutical Recent Development
  • Table 77. Hualan Biological Engineering Company Information
  • Table 78. Hualan Biological Engineering Introduction and Business Overview
  • Table 79. Hualan Biological Engineering Fibrinogen Concentrate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 80. Hualan Biological Engineering Fibrinogen Concentrate Product Offerings
  • Table 81. Hualan Biological Engineering Recent Development
  • Table 82. Harbin Pacific Biopharmaceutical Company Information
  • Table 83. Harbin Pacific Biopharmaceutical Introduction and Business Overview
  • Table 84. Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 85. Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Product Offerings
  • Table 86. Harbin Pacific Biopharmaceutical Recent Development
  • Table 87. China Meheco Group Company Information
  • Table 88. China Meheco Group Introduction and Business Overview
  • Table 89. China Meheco Group Fibrinogen Concentrate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 90. China Meheco Group Fibrinogen Concentrate Product Offerings
  • Table 91. China Meheco Group Recent Development
  • Table 92. Octapharma Company Information
  • Table 93. Octapharma Introduction and Business Overview
  • Table 94. Octapharma Fibrinogen Concentrate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 95. Octapharma Fibrinogen Concentrate Product Offerings
  • Table 96. Octapharma Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Fibrinogen Concentrate Downstream Customers
  • Table 100. Fibrinogen Concentrate Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Fibrinogen Concentrate Product Picture
  • Figure 2. Global Fibrinogen Concentrate Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Fibrinogen Concentrate Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Fibrinogen Concentrate Sales Volume (2020-2031) & (Kg)
  • Figure 5. Global Fibrinogen Concentrate Sales Price (2020-2031) & (US$/g)
  • Figure 6. Fibrinogen Concentrate Report Years Considered
  • Figure 7. Global Fibrinogen Concentrate Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Fibrinogen Concentrate Players Sales Volume Ranking (2024) & (Kg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Fibrinogen Concentrate Revenue in 2024
  • Figure 10. Fibrinogen Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Human Fibrinogen Concentrate Picture
  • Figure 12. Others Picture
  • Figure 13. Global Fibrinogen Concentrate Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Fibrinogen Concentrate Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Fibrinogen Concentrate Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
  • Figure 16. Global Fibrinogen Concentrate Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Fibrinogen Concentrate Price by Type (2020-2031) & (US$/g)
  • Figure 18. Product Picture of Surgical Procedures
  • Figure 19. Product Picture of Congenital Fibrinogen Deficiency
  • Figure 20. Product Picture of Others
  • Figure 21. Global Fibrinogen Concentrate Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Fibrinogen Concentrate Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Fibrinogen Concentrate Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
  • Figure 24. Global Fibrinogen Concentrate Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Fibrinogen Concentrate Price by Application (2020-2031) & (US$/g)
  • Figure 26. North America Fibrinogen Concentrate Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Fibrinogen Concentrate Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Fibrinogen Concentrate Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Fibrinogen Concentrate Sales Volume (%), (2020-2031)
  • Figure 38. United States Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Fibrinogen Concentrate Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Fibrinogen Concentrate Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Fibrinogen Concentrate Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Fibrinogen Concentrate Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Fibrinogen Concentrate Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Fibrinogen Concentrate Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Fibrinogen Concentrate Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Fibrinogen Concentrate Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Fibrinogen Concentrate Industrial Chain
  • Figure 60. Fibrinogen Concentrate Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed